Scientists demystify an enzyme responsible for drug and food metabolism

November 11, 2010

For the first time, scientists have been able to "freeze in time" a mysterious process by which a critical enzyme metabolizes drugs and chemicals in food. By recreating this process in the lab, a team of researchers has solved a 40-year-old puzzle about changes in a family of enzymes produced by the liver that break down common drugs such as Tylenol, caffeine, and opiates, as well as nutrients in many foods. The breakthrough discovery may help future researchers develop a wide range of more efficient and less-expensive drugs, household products, and other chemicals. The scientists' findings will be published in the journal Science on 12 November 2010.

Michael Green, an associate professor of chemistry at Penn State University and lead author of the study, explained that scientists have speculated for decades that, during the process of metabolizing chemicals in the human liver, enzymes in the family named P450 pass through a critical chemical phase-change called "Compound I," whereby an oxygen molecule is temporarily added. However, until now, no one had actually seen the process happen or even had proven that it existed. "This phase change happens quickly, and P450 just as quickly changes back to its original state," Green explained. "So the challenge was trapping the enzyme at the exact moment that it went through the Compound I stage." First, Green and his colleagues grew one of the P450 enzymes in E.coli -- bacteria found in the human gut. They then developed a method to cool the enzyme at just the right rate -- one one-thousandth of a second -- to "freeze in time" the formation process of Compound I.

Green also explained that, while all humans have a gene responsible for making the P450 enzymes, different populations of humans vary in which version of the gene they carry, and thus, which version of P450 they produce. Such P450 variations lead to differences in the way people respond to particular drugs. "With a drug such as caffeine, for example, one population of people might be fast metabolizers, while another might metabolize the drug more slowly," Green explained. "Because the risk of caffeine-induced heart attack may be higher in slow metabolizers, the ability to actually take a snapshot of the phase changes of the P450 enzymes could help us to understand better how certain chemicals can affect people in vastly different ways."

Green's P40 research may also aid future scientific discoveries in the field of pharmacology. "Adverse drug-drug interactions are a well-known problem," Green explained. "The answer to why some people have bad interactions could be understood at the level of the P450 enzymes and their state changes. Now that we can see those state changes on a molecular level, a deeper investigation is finally possible."
-end-
Green's co-author is Jonathan Little, who was an undergraduate student in Penn State's Department of Chemistry throughout the research study. Little is now a graduate student at the California Institute of Technology.

This research was supported by a grant from the National Science Foundation.

CONTACTS
Michael Green: 814-863-0925, mtg10@psu.edu
Barbara Kennedy (PIO): 814-863-4682, science@psu.edu

IMAGES
High-resolution images related to this research are online at http://www.science.psu.edu/news-and-events/2010-news/Green11-2010

Penn State

Related Caffeine Articles from Brightsurf:

Caffeine boosts problem-solving ability but not creativity, study indicates
Want to boost creativity? Caffeine may not be the way to go according to a news study by U of A psychologist Darya Zabelina.

Using caffeine as a tool to study information processing
Researchers are using caffeine to study how the brain processes information, and a new study shows the effectiveness of this approach.

More electronic device use tied to more sugar and caffeine in teens
The study, published today in PLOS ONE, found that more than 27% of teens exceed recommended sugar intake and 21% exceed recommended caffeine from soda and energy drinks.

Too much caffeine during pregnancy may damage baby's liver
Having too much caffeine during pregnancy may impair baby's liver development and increase the risk of liver disease in adulthood, according to a study published in the Journal of Endocrinology.

Algorithm provides customized caffeine strategy for alertness
A web-based caffeine optimization tool successfully designs effective strategies to maximize alertness while avoiding excessive caffeine consumption, according to preliminary results from a new study.

Caffeine gives solar cells an energy boost
Scientists from the University of California, Los Angeles (UCLA) and Solargiga Energy in China have discovered that caffeine can help make a promising alternative to traditional solar cells more efficient at converting light to electricity.

Caffeine on the mind? Just seeing reminders of coffee can stimulate our brain
A new University of Toronto study finds that just seeing reminders of coffee can arouse us, causing our minds to be more alert and attentive.

More caffeine from coffee associated with decreased rosacea risk
Consuming caffeine from coffee but not from other foods (tea, soda and chocolate) was associated with less risk of rosacea, a common chronic inflammatory skin disease where the skin appears red and flushed.

Caffeine from four cups of coffee protects the heart with the help of mitochondria
A new study shows that a caffeine concentration equivalent to four cups of coffee promotes the movement of a regulatory protein into mitochondria, enhancing their function and protecting cardiovascular cells from damage.

New report suggests three main groups of caffeine sensitivity
Coffee drinkers fall into one of three major groups based on their caffeine sensitivity, according to physician and author Dr J.W.

Read More: Caffeine News and Caffeine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.